期刊文献+

鼻咽癌患者血浆EBV DNA、VCA-IgA的检测意义 被引量:4

Significance of Detecting Plasma EBV DNA and VCA-IgA in Patients with Nasopharyngeal Carcinoma
原文传递
导出
摘要 [目的]探讨鼻咽癌患者血浆EBV DNA、VCA-IgA的检测意义。[方法]采用荧光定量PCR技术检测血浆EBV DNA水平,常规免疫酶法检测VCA-IgA抗体滴度,分别检测168例初诊鼻咽癌患者和健康对照者60人的血液标本。[结果]鼻咽癌患者血浆EBV DNA、VCA-IgA阳性率分别为34.52%(58/168)和62.50%(105/168),均明显高于健康对照者的3.33%(2/60)和6.67%(4/60)(P均<0.01);两者联合检测的敏感度显著高于单一指标检测(P<0.05)。治疗后EBVDNA及VCA-IgA阳性率均明显低于治疗前(P<0.01);肿瘤残余组患者血浆EBV DNA、VCA-IgA阳性率明显高于肿瘤完全消退组及健康对照组(P<0.01)。[结论]血浆EBV DNA、VCA-IgA联合检测在鼻咽癌诊断、近期疗效判定方面有重要价值。
作者 朱焕锋 何侠
机构地区 江苏省肿瘤医院
出处 《肿瘤学杂志》 CAS 2012年第2期111-113,共3页 Journal of Chinese Oncology
基金 江苏省自然科学基金(BK2008479)
  • 相关文献

参考文献9

  • 1Lo YM,Chan LY,Chan AT,et al.Quantitative and tempo-ral correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carci-noma[J].Cancer Res,1999,59(21):5452-5455.
  • 2Shimakage M,Dezawa T,Chatani M,et al.Proper use of serum antibody titres against Epstein-Barr virus in na-sopharyngeal carcinoma:IgA/virus capsid antigen for di-agnosis and EBV-related nuclear antigen-2for follow-up[J].Acta Oto Laryngologica,2000,120(1):100-104.
  • 3Caponigro F,Longo F,Ionna F,et al.Treatment approaches to nasopharyngeal carcinoma:a review[J].Anti Cancer Drugs,2010,21(5):471-477.
  • 4Twu CW,Wang WY,Liang WM,et al.Comparison of the prognostic impact of serum anti-ΕΒV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma[J].Int J Radiat Oncol Bial Phys,2007,67(1):130-137.
  • 5Lo YM,Chan LY,Lo KW,et al.Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma[J].Cancer Res,1999,59(6):1188-1191.
  • 6Lo YM,Chan AT,Chan LY,et al.Molecular prognostica-tion of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA[J].Cancer Res,2000,60(24):6878-6881.
  • 7孙文洁,金冶宁.鼻咽癌患者血浆EBV-DNA、血清CYFRA21-1、TSGF的检测及临床应用[J].现代肿瘤医学,2008,16(4):537-540. 被引量:4
  • 8Liu Y,Fang ZJ,Liu L,et al.Detection of Epstein-Barr virus DNA in serum or plasma for nasopharyngeal cancer:a meta-analysis[J].Genet Test Mol Biomarkers[J].2011,15(7-8):495-502.
  • 9孙剑光,郑爱平.鼻咽癌患者血浆EBV DNA水平和VCA-IgA检测的临床意义[J].现代肿瘤医学,2008,16(12):2086-2087. 被引量:12

二级参考文献18

  • 1张玉,郜红艺,冯惠霞,邓玲,黄马燕,胡斌,程钢,吴秋良,崔念基,邵建永.鼻咽癌病人血浆和外周血白细胞EB病毒DNA定量分析[J].中华医学杂志,2004,84(12):982-986. 被引量:16
  • 2Johann Gruber , Roswitha Sgone, Yan Hua Hu. Thymocyte apoptosis induced by elevated endogenous corticosterone level[ J]. Immunol, 1994,24 : 115.
  • 3Hong Lingjiang, Xin Hongtao. Progress in immunopharmacologic study of Ypingfeng Powder [ J ]. Chinese J Intergrated Traditinal and Western Med,2000,6(2) :157 -160.
  • 4Min HQ,Hong MH, Ma J, et al. A new staging system for nasopha- ryngeal carcinoma in China [ J ]. Int J Radial Oncol Biol Phys, 1994,30(5) :1037 - 1042.
  • 5Lo YM, Chan LY,Lo KW,et al. Quantitative analysis of cell- free Epstein - Barr virus DNA in plasma of patients with nasopharyngeal carcinoma[J]. Cancer Res, 1999,59(6) :1188 - 1191.
  • 6Mutirangura A, Pomthanakasem W, Theamboonlers A, et al. Epstein - Barr viral DNA in serum of patients with nasopharyngeal carcinoma[ J ]. Clin Cancer Res, 1998,4 (3) :665 - 669.
  • 7Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein - Barr virus DNA [ J ]. Cancer Res, 2000,60 ( 24 ) : 6878 - 6881.
  • 8Lo YM,Chan LY,Chan AT,et al. Quantitative and temporal correlation between circulating cell - free Epstein - Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma [ J ]. Cancer Res, 1999,59 (21) :5452 - 5455.
  • 9Dohmoto K, Hojo S, Fujita J, et al. Mechanisms of the release of CYFRA21 -1 in human lung cancer cell lines[ J]. Lung Cancer, 2000,30( 1 ) :55 -63.
  • 10Sheard MA,Vojtesek B,Simickova M,et al. Release of cytokeratin - 18 and 19 fragments (TPS and CYFRA21 - 1 ) into the extracel- lular space during apoptosis [ J ]. J Cell Biochem, 2002,85 ( 4 ) : 670 - 677.

共引文献13

同被引文献40

  • 1程树强,李立,张培生,张晓豫,史国庆.Sysmex XN-2000血细胞分析仪HFLC参数在反应性淋巴细胞检测上的应用探讨[J].中国农村卫生,2018,0(18):32-32. 被引量:1
  • 2Bauer N, Nakagawa J, Dunker C, et al. Evaluation of the automated hematology analyzer Sysmex XT -2000iVTM compared to the ADVIA : 2120 for its use in dogs, cats, and horses. Part II: Accuracy of leuko- cyte differential and reticulocyte count, impact of anticoagulant and sample aging [J]. J Vet Diagn Invest, 2012, 24(1) :74 -89.
  • 3Hildesheim A. Invited commentary: epstein -barr virus -based screen-ing for the early detection of nasopharyngcal carcinoma - - a new fron- tier [J]. Am J Epidemiol, 2013, 177(3) :251 -253.
  • 4Ho Y, Tsao SW, Zeng M, et al. STAT3 as a therapeutic target for Epstein - Barr virus (EBV) - associated nasopharyngeal carcinoma [J]. Cancer Lett, 2013, 330(2):1gl -149.
  • 5Hisashi I, Asuka N, Jun N, et al. Epstein- Barr virus (EBV) -as- sociated gastric carcinoma[ J]. Viruses, 2012, 4 (12) :3420 - 3439.
  • 6Huang Y, Wei C, Zheng K, et al. The impact of serological features in Chinese children with primary or past Epstein - Barr virus infections [J]. Virol J, 2013, 10(1):55.
  • 7龚晓昌,李金高,袁霞,廖朝晖,敖帆,邹学森,陈文学.血浆EBV DNA水平测定在监测鼻咽癌放疗后复发、转移中的临床意义[J].实用癌症杂志,2007,22(2):150-153. 被引量:17
  • 8Daris F, Carla C, Cecilia B, et al. Role of plasma EBV DNA lev- els in predicting recurrence of nasopharyngeal carcinoma in a west- ern population[J]. BMC Caneer, 2013,12( 1 ): 45-49.
  • 9Xue XC, Chen XP, Yao WH, et al. Prevalence of human papil- lomavirus and Epstein-Barr virus DNA in Chinese children with tonsillar and/or adenoidal hypertrophy[ J]. J Med Virol,2014,86 (6) : 963-967.
  • 10Li F, Song D, Lu Y, et al. Delayed-type hypersensitivity (DTH) immune response related with EBV-DNA in nasopharyn- geal carcinoma treated with autologous dendritic cell vaccination after radiotherapy[ J]. J Immunother, 2013, 36 (3) : 208-214.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部